Abbott Laboratories News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

14.04.08	Seven Summits Research Releases Comments on IBM, ABT, CAT, DD and TXT (PR Newswire)
01.04.08	Advanced Medical Optics Introduces TECNIS(R) 1-Piece Intraocular Lens in U.S. (Businesswire)
11.03.08	Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent (PR Newswire)
18.01.08	Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis (PR Newswire)
18.01.08	Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis (PR Newswire)
18.01.08	Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV-I/HTLV-II (PR Newswire)
04.12.07	Abbott Sets Aggressive Goal to Reduce Greenhouse Gas Emissions (PR Newswire)
30.11.07	The Magic Johnson Foundation and Abbott Expand Focus of 'Campaign to End Black AIDS' to African-American Women in 2008 (PR Newswire)
12.11.07	Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pediatric HIV Patients (PR Newswire)
05.11.07	Abbott Confirms FDA Advisory Panel to Review XIENCE(TM) V Drug Eluting Stent on November 29 (PR Newswire)
02.11.07	Advanced Medical Optics to Present at Two Investor Conferences in November 2007 (Businesswire)
01.11.07	Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition (PR Newswire)
25.10.07	Advanced Medical Optics Announces Third-Quarter 2007 Results (Businesswire)
02.10.07	National Laboratory Associations Come Together in Support of 'Labs Are Vital' Initiative (PR Newswire)
27.09.07	Abbott's HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care (PR Newswire)
27.09.07	Abbott's HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care (PR Newswire)
03.08.07	Abbott Chief Operating Officer Richard A. Gonzalez to Retire (PR Newswire)
31.07.07	The Princeton Review Names Abbott One of the 'Best Companies for Entry-Level Jobs' (PR Newswire)
19.07.07	Abbott Enrolls First Patient in World's First Clinical Trial Designed to Study Drug Eluting Stent Treatment in Women (PR Newswire)
18.07.07	Advanced Medical Optics Receives FDA Approval for Advanced CustomVue(TM) Monovision Procedure for the Treatment of Presbyopic Myopes (Businesswire)
29.06.07	Neue im Journal of Pediatrics veröffentlichte Studie legt nahe, dass Synagis(R) (Palivizumab) das Folgeauftreten wiederkehrender Atembeschwerden bei Frühgeborenen verringert (PR Newswire)
18.06.07	Nearly One-Third of Chicagoans Know Little or Nothing About Diabetes, Survey Says (PR Newswire)
15.06.07	Drei Studien legen nah, dass Abbotts HUMIRA(R) (Adalimumab) möglicherweise die arbeitsbezogene Leistungsfähigkeit von Patienten mit rheumatoider Arthritis verbessert (PR Newswire)
15.06.07	Three Studies Suggest Abbott's HUMIRA(R) (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis (PR Newswire)
07.06.07	Abbott's HUMIRA(R) (Adalimumab) Approved in the European Union for the Treatment of Crohn's Disease (PR Newswire)
22.05.07	Neue Datenauswertung zeigt, dass die Behandlung mit Abbotts HUMIRA(R) (Adalimumab) krankheitsbedingte Krankenhauseinweisungen von Morbus Crohn Patienten signifikant verringert (PR Newswire)
30.04.07	Abbott Named Among the 'Top 10' on The Dave Thomas Foundation's '100 Best Adoption-Friendly Workplaces' List (PR Newswire)
27.02.07	HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment of Crohn's Disease (PR Newswire)
08.01.07	Abbott m2000(TM) Molecular Diagnostic Instrument and Viral Load Tests for HIV-1 and HCV Approved in Canada (PR Newswire)
04.12.06	Abbott Introduces CE-Marked DNA Tests in Europe for the Detection of Chromosomal Abnormalities Associated With Leukemia (PR Newswire)
06.11.06	Wall Street Update: Freundlicher Mittagshandel (Aktiencheck)
02.11.06	Abbott Fund, Baylor College of Medicine and the First Lady of Malawi Open the First Clinic for HIV-Infected Children in Malawi (PR Newswire)
02.11.06	Abbott Fund, Baylor College of Medicine and the First Lady of Malawi Open the First Clinic for HIV-Infected Children in Malawi (PR Newswire)
26.10.06	Abbott's HUMIRA(R) (Adalimumab) Granted FDA Priority Review for the Treatment of Moderately to Severely Active Crohn's Disease (PR Newswire)
11.10.06	Abbott Awards Virginia Mother $130,000 in National Similac(R) Contest (PR Newswire)
19.07.06	Abbott Announces Strong Second-Quarter Results and Raises Full-Year Earnings Outlook (PR Newswire)
05.07.06	Abbott and AstraZeneca Announce Collaboration to Develop and Commercialize CRESTOR(R) and Next-Generation TriCor(R) (ABT-335) Fixed-Dose Combination (PR Newswire)
05.07.06	Abbott and AstraZeneca Announce Collaboration to Develop and Commercialize CRESTOR(R) and Next-Generation TriCor(R) (ABT-335) Fixed-Dose Combination (PR Newswire)
03.07.06	Neue Tabletten-Darreichungsform von Abbotts Kaletra(R) (Lopinavir/Ritonavir) in Europa zugelassen (PR Newswire)
03.07.06	Abbott's New Tablet Formulation of Kaletra(R) (lopinavir/ritonavir) Approved in Europe (PR Newswire)
26.06.06	Abbott Receives FDA Approval for New HUMIRA(R) Delivery Device (PR Newswire)
26.06.06	Abbott Receives FDA Approval for New HUMIRA(R) Delivery Device (PR Newswire)
23.06.06	Jüngste Phase-III-Daten beweisen, dass Abbotts HUMIRA(R) (Adalimumab) die Reduzierung der Anzeichen und Symptome von ankylosierender Spondylitis über den Zeitraum von einem Jahr aufrechterhält (PR Newswire)
07.06.06	HUMIRA(R) (Adalimumab) von Abbott erhält Zulassung in der Europäischen Union für die Behandlung der schweren ankylosierenden Spondylitis (Morbus Bechterew) (PR Newswire)
22.05.06	Promising Pivotal Phase III Data Show Abbott's Humira(R) (Adalimumab) Maintained Clinical Remission in Patients With Crohn's Disease Through One Year (PR Newswire)
28.04.06	HUMIRA(R) (Adalimumab) von Abbott erhält positiven Bericht von der Europäischen Arzneimittelagentur zur Behandlung von ankylosierender Spondylitis (PR Newswire)
31.03.06	Abbott and Morgan Stanley Welcome the 14th Annual International Biotechnology Convention to Chicago for Its Midwestern Debut (PR Newswire)
13.03.06	Seven Summits Research Releases Comments on PFE, CVX, VOD, ABT, and WM (PR Newswire)
25.01.06	Abbott Reports Record Sales, Earnings and Cash Flow in 2005 (PR Newswire)
23.12.05	Medialink: 'Tis the Season for a Doctor's Visit? (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone
20.12.24		Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones
20.12.24		Dow Jones aktuell: Dow Jones notiert am Mittag im Plus
20.12.24		Börse New York in Grün: So steht der NASDAQ 100 aktuell
20.12.24		SPI-Handel aktuell: SPI zum Handelsende leichter
20.12.24		Schwacher Handel: SMI schliesst mit Verlusten
20.12.24		Verluste in Europa: Euro STOXX 50 letztendlich leichter
20.12.24		Handel in Europa: STOXX 50 schliesst im Minus

20.12.24

Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone

20.12.24

Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones

20.12.24

Dow Jones aktuell: Dow Jones notiert am Mittag im Plus

20.12.24

Börse New York in Grün: So steht der NASDAQ 100 aktuell

20.12.24

SPI-Handel aktuell: SPI zum Handelsende leichter

20.12.24

Schwacher Handel: SMI schliesst mit Verlusten